Documents
-
- Download
- 1-s2.0-S0360301623003802-main_oe2oe
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Coverage of lateral lymph nodes in rectal cancer patients with routine radiotherapy practice and associated locoregional recurrence rates
Background & purpose: Involved internal iliac and obturator lateral lymph nodes (LLNs) are a known risk factor for ipsi-lateral local recurrences (LLR) in rectal cancer. This study examined coverage of LLNs with routine radiotherapy practice in the Netherlands and associated LLR rates.
Materials & methods: Patients with a primary tumor ≤8cm of the anorectal junction, cT3-4 stage and at least one internal iliac or obturator LLN with short-axis ≥5mm who received neoadjuvant (chemo)radiotherapy, were selected from a national, cross-sectional study of rectal cancer patients treated in the Netherlands in 2016. MR-images and radiotherapy treatment plans were reviewed regarding segmented LLNs as gross-tumor volume (GTV), location of LLNs within clinical target volume (CTV), and received proportion of the planned radiotherapy dose.
Results: A total of 223 out of 3057 patients with at least one LLN ≥5mm were selected. Of those, 180 (80.7%) LLNs...
Show moreBackground & purpose: Involved internal iliac and obturator lateral lymph nodes (LLNs) are a known risk factor for ipsi-lateral local recurrences (LLR) in rectal cancer. This study examined coverage of LLNs with routine radiotherapy practice in the Netherlands and associated LLR rates.
Materials & methods: Patients with a primary tumor ≤8cm of the anorectal junction, cT3-4 stage and at least one internal iliac or obturator LLN with short-axis ≥5mm who received neoadjuvant (chemo)radiotherapy, were selected from a national, cross-sectional study of rectal cancer patients treated in the Netherlands in 2016. MR-images and radiotherapy treatment plans were reviewed regarding segmented LLNs as gross-tumor volume (GTV), location of LLNs within clinical target volume (CTV), and received proportion of the planned radiotherapy dose.
Results: A total of 223 out of 3057 patients with at least one LLN ≥5mm were selected. Of those, 180 (80.7%) LLNs were inside the CTV, of which 60 (33.3%) were segmented as GTV. Overall, 202 LLNs (90.6%) received >95% of the planned dose. Four-year LLR rates were not significantly higher for LLNs situated outside the CTV compared to inside (4.0% vs. 12.5%, p=.092) or when receiving <95% versus >95% of the planned radiotherapy dose (7.1% vs. 11.3%, p=.843), respectively. Two of seven patients who received a dose-escalation of 60Gy developed a LLR (4-year LLR rate 28.6%).
Conclusion: This evaluation of routine radiotherapy practice showed that adequate coverage of LLNs was still associated with considerable 4-year LLR rates. Techniques resulting in better local control for patients with involved LLNs need to be explored further.
Show less- All authors
- Sluckin, T.C.; Hazen, S.M.J.A.; Horsthuis, K.; Beets-Tan, R.G.H.; Antonisse, I.E.; Berbee, M.; Bockel, L.W. van; Boer, A.H.; Ceha, H.M.; Cnossen, J.S.; Geijsen, E.D.; Hartogh, M.D. den; Hendriksen, E.M.; Intven, M.P.W.; Leseman-Hoogenboom, M.M.; Meijnen, P.; Muller, K.; Oppedijk, V.; Rozema, T.; Rutten, H.; Spruit, P.H.; Stam, T.C.; Velema, L.A.; Verrijssen, A.S.E.; Vos-Westerman, J.; Tanis, P.J.; Marijnen, C.A.M.; Kusters, M.; Dutch Snapshot Res Grp
- Date
- 2023-10-01
- Volume
- 117
- Issue
- 2
- Pages
- 422 - 433